KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Return on Invested Capital (2016 - 2026)

Bristol Myers Squibb has reported Return on Invested Capital over the past 17 years, most recently at 0.0% for Q1 2026.

  • Quarterly Return on Invested Capital changed 0.0% to 0.0% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.0% through Mar 2026, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Invested Capital was 0.0% for Q1 2026 at Bristol Myers Squibb, down from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q1 2023 and troughed at 0.01% in Q1 2024.
  • The 5-year median for Return on Invested Capital is 0.0% (2022), against an average of 0.0%.
  • Year-over-year, Return on Invested Capital decreased -1bps in 2024 and then rose 1bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then rose by 21bps to 0.0% in 2023, then crashed by -903bps to 0.0% in 2024, then soared by 87bps to 0.0% in 2025, then dropped by -5bps to 0.0% in 2026.
  • Per Business Quant, the three most recent readings for BMY's Return on Invested Capital are 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).